Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Rosuvastatin superior to pravastatin or simvastatin in hypercholesterolemia trial

Jan. 31, 2003

FDA issues complete response letter for Aldurazyme

Jan. 30, 2003

Alliance and Baxter to restructure Oxygent agreement

Jan. 30, 2003

HMG-CoA-inhibitory simvastatin analogues covered by Ranbaxy patent

Jan. 30, 2003

Boehringer Ingelheim claims new cathepsin inhibitors for osteoporosis, arthritis, etc.

Jan. 30, 2003

FM-VP4 safe and well tolerated in phase I study

Jan. 29, 2003

Clinical testing of new PPARgamma agonist from Tularik commences

Jan. 28, 2003

Plant-produced alpha-galactosidase A receives orphan drug status for Fabry's disease

Jan. 27, 2003

Oxandrolone reported to prevent involuntary weight loss in cancer and HIV infection

Jan. 27, 2003

Similar benefits found for rHuEPO and darbepoetin alfa in dialysis and renal anemia

Jan. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...